No Data
No Data
Nutrien Maintained at Outperform With a US$46.66 Price Target at RBC Capital Markets
Canadian Stock Movers for Thursday | Bausch Health Companies Inc Was the Top Gainer; Medical Devices & Instruments Led Gains
With 71% Ownership, Nutrien Ltd. (TSE:NTR) Boasts of Strong Institutional Backing
Fertilizer Equities Including Nutrien Mixed Over Past Week, RBC Capital Markets Says
Gold Rises as Russia's Nuclear Threats Prompt Safe-Haven Buying
Berenberg Bank Maintains Nutrien(NTR.US) With Buy Rating, Cuts Target Price to $54
No Data